Cargando…
Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071104/ https://www.ncbi.nlm.nih.gov/pubmed/36475522 http://dx.doi.org/10.3324/haematol.2022.281856 |
| _version_ | 1785019131320336384 |
|---|---|
| author | Zeidner, Joshua F. Mazerolle, Flora Norton, Jonathan Regnault, Antoine Kristo, Fjoralba Romero, Heather Fram, Robert J. Faller, Douglas V. Dalal, Mehul Ades, Lionel Sekeres, Mikkael A. |
| author_facet | Zeidner, Joshua F. Mazerolle, Flora Norton, Jonathan Regnault, Antoine Kristo, Fjoralba Romero, Heather Fram, Robert J. Faller, Douglas V. Dalal, Mehul Ades, Lionel Sekeres, Mikkael A. |
| author_sort | Zeidner, Joshua F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10071104 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100711042023-04-05 Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes Zeidner, Joshua F. Mazerolle, Flora Norton, Jonathan Regnault, Antoine Kristo, Fjoralba Romero, Heather Fram, Robert J. Faller, Douglas V. Dalal, Mehul Ades, Lionel Sekeres, Mikkael A. Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-12-07 /pmc/articles/PMC10071104/ /pubmed/36475522 http://dx.doi.org/10.3324/haematol.2022.281856 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Zeidner, Joshua F. Mazerolle, Flora Norton, Jonathan Regnault, Antoine Kristo, Fjoralba Romero, Heather Fram, Robert J. Faller, Douglas V. Dalal, Mehul Ades, Lionel Sekeres, Mikkael A. Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes |
| title | Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes |
| title_full | Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes |
| title_fullStr | Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes |
| title_full_unstemmed | Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes |
| title_short | Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes |
| title_sort | time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10071104/ https://www.ncbi.nlm.nih.gov/pubmed/36475522 http://dx.doi.org/10.3324/haematol.2022.281856 |
| work_keys_str_mv | AT zeidnerjoshuaf timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT mazerolleflora timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT nortonjonathan timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT regnaultantoine timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT kristofjoralba timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT romeroheather timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT framrobertj timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT fallerdouglasv timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT dalalmehul timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT adeslionel timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes AT sekeresmikkaela timewithouttransfusionrelianceanovelpatientcentricmetricfornewtherapiesinmyelodysplasticsyndromes |